Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Neuroradiology: Page 48
SPECT spots differences in dementia subtype, Alzheimer's
By
Rebekah Moan
A study 20 years in the making reveals that SPECT combined with the radioactive compound iodine-123 FP-CIT distinguishes dementia with Lewy bodies from Alzheimer's disease. Dementia with Lewy bodies is what is believed to have led to actor Robin Williams' suicide.
February 7, 2021
Stroke ambulances improve patient outcomes
By
Kate Madden Yee
Ambulances fitted to function as mobile stroke units -- with CT, point-of-care lab testing, and thrombolysis capabilities -- improved the outcomes among patients who suffer acute ischemic stroke, according to a study published February 2 in
JAMA
.
February 1, 2021
Canon expands utility of AiCE in MRI
By
AuntMinnie.com staff writers
Canon Medical Systems said that its Advanced intelligent Clear-IQ Engine (AiCE) deep-learning reconstruction technology is now available for a wider range of clinical applications on its Vantage Orian 1.5-tesla MRI scanner.
January 31, 2021
MRI guidance improves epilepsy treatment surgery
By
Kate Madden Yee
Using MRI to guide stereotactic laser corpus callosotomy for epilepsy treatment is more effective than using a surgical robot for the procedure, according to a study published January 22 in the
Journal of Neurosurgery
.
January 27, 2021
Mass Eye and Ear promotes Cunnane
By
AuntMinnie.com staff writers
Massachusetts Eye and Ear in Boston has appointed neuroradiologist Dr. Mary Beth Cunnane as chief of radiology.
January 25, 2021
fMRI gets to the bottom of smell, taste dysfunction from COVID-19
By
Emily Hayes
Functional MRI (fMRI) was helpful for evaluating persistent smell and taste dysfunction in a patient with COVID-19, according to a case report published January 22 in
JAMA Neurology
. The orbitofrontal cortex appears to be particularly relevant in understanding the cause of symptoms, Kuwaiti researchers reported.
January 21, 2021
Viz.ai launches image software for clinical trials
By
AuntMinnie.com staff writers
Artificial intelligence software developer Viz.ai has launched an application designed to identify brain abnormalities in images of patients and use that information for placement in clinical trials.
January 20, 2021
PET identifies tau's origin in Alzheimer's disease
By
Erik L. Ridley
An automated PET image analysis method can track the development of tau protein clumps in the brains of people with Alzheimer's disease, revealing an important clue in how the devastating disease could potentially be treated, according to research published online January 20 in
Science Translational Medicine
.
January 20, 2021
PET shows aerobic exercise has little effect on amyloid
By
Wayne Forrest
While aerobic exercise is good for the cardiovascular system, PET images show a weekly regimen of this activity does nothing to change the status of beta-amyloid buildup in older adults with elevated levels of the marker for Alzheimer's disease, according to a study published online January 14 in
PLOS One
.
January 19, 2021
HIV drugs correlate with lower brain volumes on MRI
By
Rebekah Moan
One of the largest-ever neuroimaging studies of individuals with HIV used MRI to reveal that lower current CD4+ T-cell counts were associated with smaller hippocampal and thalamic volumes in the brain. Also, the subset of participants not receiving treatment had smaller putamen volumes, according to findings published January 15 in
JAMA Network Open
.
January 15, 2021
Anavex wins $1M grant for PET research
By
AuntMinnie.com staff writers
Biopharmaceutical firm Anavex Life Sciences has received a nearly $1Â million grant from the Michael J. Fox Foundation to investigate using PET imaging biomarkers to assess its Anavex 2-73 drug for treating Parkinson's disease.
January 11, 2021
Study finds COVID-19 brain damage but no infection
By
Kate Madden Yee
A study conducted by a team of researchers from the U.S. National Institutes of Health found brain damage in patients who died of COVID-19 but no signs of SARS-CoV-2 in tissue samples. The research was published December 30 in the
New England Journal of Medicine
.
January 3, 2021
Previous Page
Page 48 of 238
Next Page